Skip to main content

Month: March 2024

Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider

Dallas, TX, March 21, 2024 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), a global leader in drug testing using hair analysis, is proud to announce its recognition as one of the Top 10 Employee Health Testing Services Providers for 2024 by ManageHR. This prestigious accolade highlights Psychemedics’ commitment to excellence and innovation in the field of employee health testing. ManageHR’s annual list recognizes companies that excel in providing cutting-edge solutions and services for employee health testing. Psychemedics was selected for its exceptional performance, industry leadership, and dedication to delivering reliable and accurate testing services. “We are honored to be recognized as one of the Top 10 Employee Health Testing Services Providers,” said Brian Hullinger, Chief Executive Officer and President of Psychemedics...

Continue reading

SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research

MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 21, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced that MitoCareX Bio Ltd. (“MitoCareX”), the Company’s venture with Dr. Alon Silberman that focuses on drug discovery and the development of cancer therapeutics by targeting the mitochondrial SLC25 protein family, had virtually screened millions of small molecules by using its computationally advanced drug discovery platform, which resulted in the identification of several molecules that could be used for potential anti-cancer treatments. As...

Continue reading

NextCure Provides Business Update and Reports Full Year 2023 Financial Results

Prioritizing and focusing on highest-value opportunities NC410 (ovarian and CRC) and LNCB74 (B7-H4 ADC) Based on early evidence of clinical activity with NC410 combo, expanding ovarian and CRC cohorts with data updates in 2024 LNCB74, in collaboration with LegoChem, planned filing of an IND by year-end 2024 Restructuring of our operations, including a reduction in workforce to better align resources toward prioritized programs Cash of approximately $108 million, combined with the restructuring, now expected to fund operations into the second half of 2026BELTSVILLE, Md. – March 21, 2024, March 21, 2024 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer today provided a business update...

Continue reading

Maris-Tech Announces Full Year 2023 Financial Results and a Record Revenue Year

Annual Revenues of Approximately $4.0 million for the Year Ended December 31, 2023, Representing 60% Growth in Revenue Over 2022 REHOVOT, Israel, March 21, 2024 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a B2B provider of artificial intelligence (“AI”) accelerated video solutions for edge platforms, today announced its financial results for the year ended December 31, 2023. Revenues for the year ended December 31, 2023, were approximately $4.0. million, an increase of 60% compared to approximately $2.5 million for the year ended December 31, 2022. Gross profit for the year ended December 31, 2023, was approximately $1.9 million, an increase of 138% compared to approximately $0.8 million for the year ended December 31, 2022. Net loss for the year ended December 31, 2023, was approximately...

Continue reading

Alliance Entertainment Begins Installation of Cost-Saving OPEX Sure Sort X Sortation Technology at Kentucky Warehouse

3 Year ROI With Current Processes Redirected into Sure Sort X with Expected Time Frame Reduction Through Streamlining Additional Processes, New Capabilities and Continuous Improvement PLANTATION, Fla., March 21, 2024 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a global distributor and wholesaler specializing in music, movies, video games, electronics, arcades, toys, and collectibles, has commenced installation at its Kentucky facility of Sure Sort® X, a cost-saving sortation technology system from warehouse automation solutions provider OPEX®, to be completed April 1st, 2024. Utilizing this new Sure Sort X technology will result in annual labor savings of nearly $400,000 for Alliance Entertainment, along with an immediate savings of $460,000 from avoiding retrofitting older sorting technology set...

Continue reading

Connexa Announces Entry into an Agreement to Acquire a 70% Stake in Yuanyu Enterprise Management Co., Limited for Cash and Shares

Hong Kong-based, operating matchmaking services in emerging Love & Marriage sector. Owner of multiple patented matchmaker AI technologies. Hand-in-Hand branded retail stores, key advantage over competition. FY23 royalty revenue of $1.9 million with licensing agreements in place to deliver $77 million in royalties over the next 3 years.Windsor Mills, MD, March 21, 2024 (GLOBE NEWSWIRE) — Connexa Sports Technologies Inc. (Nasdaq:CNXA) today announced that, subject to shareholder approval, it has signed definitive share purchase and share exchange agreements to acquire a 70% stake in Yuanyu Enterprise Management Co., Limited (YYEM) for a combined value of $56 million. The transaction will be carried out in two steps, with an initial 20% stake having been completed against payment of $16.5 million in cash, and the residual...

Continue reading

LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy Cancer Treatments

— Three Clinical Trials Currently Underway for Treating Ovarian, Lung and Sarcoma Cancers — PASADENA, Calif., March 21, 2024 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical-stage pharmaceutical company developing a new class of cancer therapy to enhance chemotherapy and immunotherapy, today provided an update on the Company’s progress with its proprietary compound, LB-100. “Clinical trials are underway at leading cancer centers in the United States and Spain using LB-100 in combination with chemotherapy and immunotherapy that we are hopeful will provide new and effective treatment options for patients with lung, ovarian and sarcoma cancers,” said Bas van der Baan, LIXTE’s President and Chief Executive Officer. Clinical trials are taking place at the...

Continue reading

Kura Sushi USA to Announce Fiscal Second Quarter 2024 Financial Results on April 4, 2024

IRVINE, Calif., March 21, 2024 (GLOBE NEWSWIRE) — Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”), (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced that it will host a conference call to discuss fiscal second quarter 2024 financial results on Thursday, April 4, 2024 at 5:00 p.m. ET. A press release with fiscal second quarter 2024 financial results will be issued that same day after the market closes. Hosting the conference call and webcast will be Hajime “Jimmy” Uba, President and Chief Executive Officer, Jeff Uttz, Chief Financial Officer, and Benjamin Porten, SVP Investor Relations & System Development. Interested parties may listen to the conference call via telephone by dialing 201-689-8471. A telephone replay will be available shortly after the call has concluded and can be accessed...

Continue reading

CISO GLOBAL RECOGNIZED ON CRN’S 2024 MSP 500 LIST IN THE SECURITY 100 CATEGORY

Scottsdale, Ariz., March 21, 2024 (GLOBE NEWSWIRE) — CISO Global, Inc . (NASDAQCM: CISO), an industry leader in proprietary software, managed cybersecurity, and compliance, announced today that CRN®, a brand of The Channel Company, has named CISO Global to its Managed Service Provider (MSP) 500 list in the Security 100 category for 2024. The MSP 500 list compiled by CRN serves as a comprehensive guide to identifying and recognizing the top Managed Service Providers (MSPs) in North America. MSPs play a crucial role in supporting businesses by offering managed services that enhance efficiency, simplify IT solutions, and optimize return on investment. CISO Global is an industry leader with a proactive approach to managed cybersecurity and compliance. In addition to delivering a comprehensive suite of end-to-end managed security services,...

Continue reading

Coveo to Showcase the Significant Impact of AI and GenAI to Improve Digital Experiences at 10th Edition of Relevance 360° Virtual Event

AI Futurist Zack Kass, former Head of GTM for OpenAI; Rowan Curran, Forrester Senior Analyst; and senior executives from SAP and Xero will join Coveo Executives to talk about how AI Search and Generative Answering at every point of experience is a total ‘gain’ changer for enterprisesCoveo to Showcase the Significant Impact of AI and GenAI to Improve Digital Experiences at 10th Edition of Relevance 360° Virtual EventCoveo announces the speakers for the 10th edition of Coveo Relevance 360° on March 27, 2024, at 11:00AM ET for a virtual 60-minute AI Strategy event.MONTREAL and SAN FRANCISCO, March 21, 2024 (GLOBE NEWSWIRE) — Coveo (TSX:CVO), a leading provider of enterprise AI platforms that enable individualized, connected, and trusted digital experiences at scale with AI search, AI recommendations, GenAI answering...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.